跳至主要内容
临床试验/NCT05272020
NCT05272020Unknown不适用

PRognosis of Outcome and Recuperation of Cardiac Hemodynamic Function After Aortic Valve REplacement in Aortic Valve Stenosis

Jessa Hospital2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2021年3月22日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
150
试验地点
2
主要终点
Outcome defined by the occurrence of a major cardiac event

研究概览

简要总结

Indication for aortic valve replacement (AVR) in aortic stenosis (AS) is currently based on the classical triad of clinical AS symptoms, estimation of AS severity, and cardiac repercussion at rest. However, presence of symptoms in elderly is often subjective and underreported, and cardiac function analysis at rest underestimates the true impact of the chronic afterload increase. This complicates the diagnosis and hampers timely aortic valve replacement therapy with an impact on prognosis and cardiac function recovery. Exercise imaging in AS may reveal underlying cardiac repercussion and symptoms at an earlier stage and therefore impact prognosis and cardiac function recovery after AVR. Therefore the principal objective of this study is to reveal the factors that determine clinical outcome and hemodynamic function recovery after AVR in AS.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Every patient above 18 years of age with an echocardiographic established moderate to severe AS
  • A guideline indication for aortic valve replacement therapy

排除标准

  • Unable to perform exercise testing
  • Previous aortic valve intervention
  • More than moderate other valvular disease
  • Patients refusing participation or unwilling to sign the informed consent

结局指标

主要结局

Outcome defined by the occurrence of a major cardiac event

时间窗: 18 months

either 1. Death of cardiovascular origin, or 2. Hospitalization for heart failure, or 3. Deterioration of hemodynamic function during an 18 month follow-up period after AVR.

次要结局

未报告次要终点

研究者

发起方
Jessa Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sarah Hoedemakers

Sarah Hoedemakers

Jessa Hospital

研究点 (2)

Loading locations...

相似试验